All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @benross02 on TikTok · 46s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @benross02's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Boys I've been on MK for over a month now. Let me just say it's been great process, man
  2. 0:04I mean, I'm the strongest I've ever been I've been losing the fat and gaining muscle at the same time like new be gains even though
  3. 0:10I've been in the gym
  4. 0:11I've actually also grown two centimeters as well which is kind of crazy to think about and just one month
  5. 0:18I'll probably won't be able to grow out much longer now because I'm a little bit older now
  6. 0:22So but I've grown two centimeters my hair's growing really quickly
  7. 0:27Skins better my sleeps better. It's just been a crazy process, man
  8. 0:32We had like if y'all want to know where I get it
  9. 0:34Just DM me but like I don't really care about promoting it too much
  10. 0:37I just want to give like the real real results
  11. 0:39So it's been insane man. I would definitely have taken it sooner if I don't be like this

@benross02's MK-677 claims need a reality check

benross⭐️

TikTok creator

180.4K viewsWatch on TikTok

Quick answer

MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone secretion and raises IGF-1 levels. The creator reports body composition changes, height gain, improved sleep, skin, and hair after approximately one month of unsupervised use sourced through direct message referrals. While some reported effects align with known GH secretagogue activity, the height gain claim is not physiologically consistent with adult skeletal biology, and the absence of medical oversight, baseline labs, or verified compound quality makes individual attribution of any outcome impossible.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @benross02's MK-677 claims need a reality check, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@benross02's MK-677 claims need a reality check should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@benross02's MK-677 claims need a reality check" from benross⭐️. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone secretion and raises IGF-1 levels.

The reason this review is not generic is the source wording and the canonical claim label "peptides im giving yall the real answers mk677 mk gym summer hea." In this clip, the useful excerpt is: "Boys I've been on MK for over a month now." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Copinschi et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone secretion and raises IGF-1 levels.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone secretion and raises IGF-1 levels. The creator reports body composition changes, height gain, improved sleep, skin, and hair after approximately one month of unsupervised use sourced through direct message referrals. While some reported effects align with known GH secretagogue activity, the height gain claim is not physiologically consistent with adult skeletal biology, and the absence of medical oversight, baseline labs, or verified compound quality makes individual attribution of any outcome impossible.
  • MK-677 is not FDA-approved for any human indication and is classified as a research compound; use outside clinical supervision carries unquantified risk.
  • Copinschi et al. (1997, Sleep) confirmed MK-677 increases slow-wave and REM sleep, making the sleep improvement claim the most scientifically defensible part of this video.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • MK-677 is not FDA-approved for any human indication and is classified as a research compound; use outside clinical supervision carries unquantified risk.
  • Copinschi et al. (1997, Sleep) confirmed MK-677 increases slow-wave and REM sleep, making the sleep improvement claim the most scientifically defensible part of this video.
  • Adult skeletal height does not increase in response to GH secretagogues after growth plate fusion; the two-centimeter claim is not supported by any published biology.
  • Nass et al. (2008, Annals of Internal Medicine) found elevated fasting glucose and a higher rate of adverse cardiac events in older adults using MK-677, flagging metabolic risk that young users often dismiss.
  • WADA prohibits MK-677 in competitive athletes under the category of growth hormone releasing factors, meaning any tested athlete using this compound risks disqualification.
  • Sourcing compounds through DM referrals on social media provides no purity verification, no dosing accuracy, and no legal or medical accountability if adverse effects occur.
  • Body recomposition effects from GH secretagogues are plausible in research settings but have not been reproduced in controlled trials at the scale or speed described in this video.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @benross02 actually say?

The short version: this creator spent about a minute telling 180,000 people that one month of MK-677 made him "the strongest I've ever been," helped him lose fat and gain muscle simultaneously, and caused him to grow two centimeters in height. He also credited it with faster hair growth, better skin, and improved sleep. Then he offered to DM people his source.

That last part matters. Directing followers to a private supplier for an unregulated compound with no dosing guidance, no medical supervision, and no accountability is not "giving the real real results." It is an uncontrolled experiment with an audience, and the 180K view count means a lot of people received this as legitimate health advice.

Does the science back this up?

Some of it, partially. MK-677 is a ghrelin mimetic and growth hormone secretagogue, meaning it stimulates the pituitary to release more growth hormone and, downstream, raises IGF-1 levels. The effects he describes, including better sleep and modest body composition changes, are biologically plausible and have partial research support. The height claim is almost certainly not what he thinks it is.

On sleep: Copinschi et al. (1997, Sleep) found that MK-677 increased REM sleep and slow-wave sleep in healthy adults, so "my sleep's better" is actually one of the more defensible things he said. On body composition: Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) found modest lean mass increases with oral MK-677 in healthy subjects, though the effect sizes were not dramatic and fat loss was not a primary finding. On height: in skeletally mature adults, growth hormone elevation does not lengthen bones. That is not how adult bone physiology works.

What did they get wrong (or right)?

The height claim is the biggest problem here. He says he "grown two centimeters" and seems to attribute this to MK-677. In adults with closed growth plates, this does not happen from a GH secretagogue. What can happen is spinal decompression from improved sleep posture and reduced cortisol, or simple measurement error. Two centimeters in a month from a drug is not a credible claim, and presenting it as fact to a young audience that may still be hoping to grow is irresponsible.

The simultaneous fat loss and muscle gain claim, sometimes called body recomposition, is plausible under specific conditions, particularly in beginners or in individuals returning after a break, where elevated GH and IGF-1 can support both processes. He may have experienced something real here. But calling it a drug effect without controlling for training, diet, sleep, and stress is not evidence of anything.

What he got right: the sleep improvement claim has legitimate mechanistic support. Hair and skin changes are consistent with elevated IGF-1 signaling. These are not fabricated outcomes.

What should you actually know?

MK-677 is not approved by the FDA for any indication. It is not a peptide in the technical sense but a small molecule, and it is currently banned by WADA in competitive sports. It raises blood glucose and insulin levels, which is a real concern for anyone with metabolic risk, and long-term safety data in healthy adults is thin. Nass et al. (2008, Annals of Internal Medicine) studied MK-677 in older adults and found increases in fasting glucose and a higher rate of congestive heart failure in the treatment group, though that was an older population.

The bigger issue is access. Getting this compound from a DM referral means no purity testing, no verified dosing, no oversight, and no recourse if something goes wrong. Compounded and research-grade versions vary widely in quality. Anyone considering a GH secretagogue should be doing it under clinical supervision with baseline labs, not because someone on TikTok had a good month.

  • MK-677 has a legitimate research profile, but it is not approved for human use outside clinical trials
  • Height gain in adults from this compound is not supported by any published evidence
  • Sleep and skin improvements are biologically plausible based on GH and IGF-1 signaling
  • Sourcing from unverified suppliers carries serious contamination and dosing risks

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

benross⭐️ · TikTok creator

180.4K views on this video

im giving yall the real answers #mk677 #mk #gym #summer #health #glowup #skin #foryou

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about mk-677?

MK-677 is not FDA-approved for any human indication and is classified as a research compound; use outside clinical supervision carries unquantified risk.

What does the video say about copinschi et al. (1997, sleep) confirmed mk-677 increases slow-wave?

Copinschi et al. (1997, Sleep) confirmed MK-677 increases slow-wave and REM sleep, making the sleep improvement claim the most scientifically defensible part of this video.

What does the video say about adult skeletal height does not increase in response to gh?

Adult skeletal height does not increase in response to GH secretagogues after growth plate fusion; the two-centimeter claim is not supported by any published biology.

What does the video say about nass et al. (2008, annals of internal medicine) found elevated?

Nass et al. (2008, Annals of Internal Medicine) found elevated fasting glucose and a higher rate of adverse cardiac events in older adults using MK-677, flagging metabolic risk that young users often dismiss.

What does the video say about wada prohibits mk-677 in competitive athletes under the category of?

WADA prohibits MK-677 in competitive athletes under the category of growth hormone releasing factors, meaning any tested athlete using this compound risks disqualification.

What does the video say about sourcing compounds through dm referrals on social media provides no?

Sourcing compounds through DM referrals on social media provides no purity verification, no dosing accuracy, and no legal or medical accountability if adverse effects occur.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by benross⭐️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.